Macrophage-Mediated Delivery of Hypoxia-Activated Prodrug Nanoparticles

被引:2
|
作者
Evans, Michael A.
Shields, C. Wyatt
Krishnan, Vinu
Wang, Lily Li-Wen
Zhao, Zongmin
Ukidve, Anvay
Lewandowski, Michael
Gao, Yongsheng
Mitragotri, Samir
机构
关键词
D O I
10.1002/adtp.202000183
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma
    Hao, Yinghong
    Zhu, Wenzhi
    Li, Jie
    Lin, Ruirui
    Huang, Wenting
    Ul Ain, Qurat
    Liu, Kaicai
    Wei, Ning
    Cheng, Delei
    Wu, Yi
    Lv, Weifu
    JOURNAL OF CONTROLLED RELEASE, 2024, 372 : 155 - 167
  • [42] Recent Advances in Macrophage-Mediated Drug Delivery Systems
    Liang, Tiantian
    Zhang, Rongtao
    Liu, Xianbin
    Ding, Qian
    Wu, Siqiong
    Li, Chunhong
    Lin, Yan
    Ye, Yun
    Zhong, Zhirong
    Zhou, Meiling
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 2703 - 2714
  • [43] Harnessing Microbial Effectors for Macrophage-Mediated Drug Delivery
    Van Staden, Anton Du Preez
    Visser, Johan G.
    Powrie, Yigael S. L.
    Smith, Carine
    ACS OMEGA, 2024, 9 (16): : 18260 - 18272
  • [44] Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug
    Van der Wiel, A.
    Marcus, D.
    Niemans, R.
    Yaromina, A.
    Theys, J.
    Mowday, A.
    Ashoorzadeh, A.
    Anderson, R.
    Bull, M.
    Abbattista, M.
    Heyerick, A.
    Guise, C.
    Smaill, J.
    Patterson, A.
    Dubois, L.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S313 - S314
  • [45] Macrophage-mediated delivery of light activated nitric oxide prodrugs with spatial, temporal and concentration control
    Evans, Michael A.
    Huang, Po-Ju
    Iwamoto, Yuji
    Ibsen, Kelly N.
    Chan, Emory M.
    Hitomi, Yutaka
    Ford, Peter C.
    Mitragotri, Samir
    CHEMICAL SCIENCE, 2018, 9 (15) : 3729 - 3741
  • [46] HYPOXIA AND ENDOTOXIN INDUCE MACROPHAGE-MEDIATED SUPPRESSION OF FIBROBLAST PROLIFERATION
    BANKEY, P
    FIEGEL, V
    SINGH, R
    KNIGHTON, D
    CERRA, F
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1989, 29 (07): : 972 - 980
  • [47] Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferase
    Zhu, Rui
    Seow, Helen A.
    Baumann, Raymond P.
    Ishiguro, Kimiko
    Penketh, Philip G.
    Shyam, Krishnamurthy
    Sartorelli, Alan C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6242 - 6247
  • [48] Preclinical dose sequence and regimen optimization of the hypoxia-activated prodrug TH-302
    Sun, Jessica
    Liu, Qian
    Ahluwalia, Dharmendra
    Ferraro, Damien
    Wang, Yan
    Henjarappa, Nirupama
    Curd, John
    Matteucci, Mark
    Hart, Charles
    CANCER RESEARCH, 2009, 69
  • [49] Induction of DNA damage and repair responses by the hypoxia-activated prodrug PR-104.
    Douglas, RS
    Patterson, AV
    Yang, S
    Wilson, WR
    Siim, BG
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8973S - 8974S
  • [50] Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
    Lohse, Ines
    Rasowski, Joanna
    Cao, Pinjiang
    Pintilie, Melania
    Do, Trevor
    Tsao, Ming-Sound
    Hill, Richard P.
    Hedley, David W.
    ONCOTARGET, 2016, 7 (23) : 33571 - 33580